Search

Your search keyword '"Afd Pharmacoepi ' showing total 4,315 results

Search Constraints

Start Over You searched for: Author "Afd Pharmacoepi Remove constraint Author: "Afd Pharmacoepi Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
4,315 results on '"Afd Pharmacoepi '

Search Results

1. Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study

2. A blueprint for health technology assessment capacity building: lessons learned from Malta

3. A literature review of quality assessment and applicability to HTA of risk prediction models of coronary heart disease in patients with diabetes

5. Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate

6. Fracture patterns and associated risk factors in pediatric and early adulthood type 1 diabetes: Findings from a nationwide retrospective cohort study

7. Fracture patterns in adult onset type 1 diabetes and associated risk factors - A nationwide cohort study

9. Epidemiological surveillance of drug safety using cumulative sequential analysis in electronic healthcare data

10. Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer

11. Cognitive processes in pharmacists’ clinical decision-making

12. Forging new paths in access to medicines research: Towards equitable access for all

13. Interplay of OATP1A/1B/2B1 uptake transporters and ABCB1 and ABCG2 efflux transporters in the handling of bilirubin and drugs

14. Lifecycle HTA: Promising applications and a framework for implementation

15. Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review

16. Impact of Drug Recalls on Patients in The Netherlands: A 5-Year Retrospective Data Analysis

18. A Nomogram to Predict Severe Toxicity in DPYD Wild-Type Patients Treated With Capecitabine-Based Anticancer Regimens

19. Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients

20. The impact of scheduling ketamine as an internationally controlled substance on anaesthesia care in Sub-Saharan Africa: a case study and key informant interviews

21. ABCB1 attenuates brain exposure to the KRASG12C inhibitor opnurasib whereas binding to mouse carboxylesterase 1c influences its plasma exposure

22. Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration

23. Towards Consistency in Dietary Pattern Scoring: Standardising Scoring Workflows for Mediterranean, DASH, and MIND Diets Using 24-Hour Recall and Two Variations of a Food Frequency Questionnaire

24. Real-World Evidence to Inform Regulatory Decision Making: A Scoping Review

25. The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome

27. Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of the antimalarial drug pyronaridine in human whole blood

28. A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases

30. Predictability of human exposure by human-CYP3A4-transgenic mouse models: A meta-analysis

32. Improving expert search effectiveness: Comparing ways to rank and present search results

33. Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study

34. Within-episode repeat antibiotic prescriptions in patients with respiratory tract infections: A population-based cohort study

36. Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023

37. Outer packaging labelling of medicines in Southern African Development Community (SADC) countries: comparative analysis of requirements and transition terms for harmonisation

38. Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries

39. Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions: A cross-sectional study in six EU member states

40. The ABCB1 and ABCG2 efflux transporters limit brain disposition of the SYK inhibitors entospletinib and lanraplenib

41. Is Higher Docetaxel Clearance in Prostate Cancer Patients Explained by Higher CYP3A? An In Vivo Phenotyping Study with Midazolam

42. A case report: Management of carbamazepine intoxication using hemodialysis followed by continuous venovenous hemodialysis

43. Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis

44. Rol voor openbaar apotheker als behandelaar bij recidiverende blaasontsteking?

45. Adoption of new medicines in primary care: A comparison between the uptake of new oral anticoagulants and diabetes medicines

46. Uptake of orphan drugs in the WHO essential medicines lists

48. Exploring the pharmacists' role in optimising antithrombotic therapy in primary care: a qualitative study

49. Trends in orphan medicinal products approvals in the European Union between 2010–2022

50. Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children

Catalog

Books, media, physical & digital resources